AbCellera
solving key challenges in developing cell engager cancer treatments controlling how cells are activated only targeting cancer cells ona | AbCellera
Company
Deck Type
Sector
Industry
Deck date
May 2023
Slide
5 of 18
Related slides by other companies
Equillium
Investor Presentation
February 2024
receptor a key shared signaling hub | Equillium
Orbia
Investor Day
May 2022
solving critical world challenges with specialty compounds | Orbia
Boundless Bio
IPO
March 2024
amplified cancer cells have significantly elevated replication stress amplified amplified a | Boundless Bio
Mink Therapeutics
Investor Day
November 2022
clinical challenges multiple myeloma is still incurable car cells do more than just kill the tumor cells mink | Mink Therapeutics
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights